Does ADALIMUMAB Cause Neoplasm malignant? 2,028 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 2,028 reports of Neoplasm malignant have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.4% of all adverse event reports for ADALIMUMAB.
2,028
Reports of Neoplasm malignant with ADALIMUMAB
0.4%
of all ADALIMUMAB reports
300
Deaths
399
Hospitalizations
How Dangerous Is Neoplasm malignant From ADALIMUMAB?
Of the 2,028 reports, 300 (14.8%) resulted in death, 399 (19.7%) required hospitalization, and 41 (2.0%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 2,028 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
DENOSUMAB (698)
Which ADALIMUMAB Alternatives Have Lower Neoplasm malignant Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB